Vitalhub Corp.

TSX:VHI.TO

Medical - Healthcare Information Services

Healthcare
$6.66 +0.56%

+$0.04 today

Market cap
$421.84M
Beta
0.77
P/E (TTM)
62.1
EPS (TTM)
$0.12
52W Low $6.67High $14.64

Volume 0.23M

Average 0.41M

VHI.TO Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Vitalhub Corp.TSX: VHI.TO

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development grows, but more slowly than its trailing trend

Q1 FY2026 research & development of CA$9.04M rose 73.1% year over year, behind the +92.4% change in trailing-twelve-month research & development. Sequentially, it rose 6.8% from the prior quarter. Over 3 fiscal years it compounded at +40.5% a year.

Context

  • Research & development amounted to 26.6% of revenue in FY2025, up 4.4 pp from a year earlier.
  • Research & development increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +73.1% toward the trailing-twelve-month pace of +92.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$9.04M+6.8% QoQ
Last fiscal yearDec 2025
CA$28.95M+90.1% YoY
LTMMar 2026
CA$32.77M+92.4% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+73.1%——
1 year+90.1%——
3-year CAGR+40.5%——
5-year CAGR——
10-year CAGR——

Research & Development history

CAD · from the income statement

Latest · FY2025
28.95M CAD
Year-over-year change
+90.1%
4-year CAGR
+47.9%

Research & Development vs competitors

How VHI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +92.4% is the highest of 6, against a peer median of -25.6%.
  • Research & development amounts to 27.5% of revenue for VHI.TO, versus a peer median of 4.1%.
VHI.TO Competitors
Research & Development for VHI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$33.61M CAD+45.4%+25.2%6.6%
VHI.TOVitalhub Corp.LTM Mar 2026CA$32.77M CAD+92.4%+40.5%27.5%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$13.33M CAD-25.6%-7.0%20.0%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$4.85M CAD+31.9%-15.1%1.5%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$1.84M CAD-59.9%—66.7%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$0 USD-100.0%-39.8%0.0%
TSND.TOTerrAscend Corp.LTM Mar 2026$0 USD——0.0%
Peer median (excluding VHI.TO) —-25.6%-11.0%4.1%

Competitors are the stored peer set for VHI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue24.66M39.97M52.51M68.59M108.97M
Cost of Revenue5.24M7.03M9.7M13.1M32.46M
Gross Profit19.43M32.94M42.81M55.49M76.51M
Gross Margin78.8%82.4%81.5%80.9%70.2%
Research & Development6.05M10.43M12.17M15.23M28.95M
Selling, General & Admin10.41M13.97M18.8M24.56M35.39M
Operating Expenses19.13M28.28M42.81M45.75M64.34M
Depreciation & Amortization2.68M3.87M4.98M5.96M11.08M
EBITDA1.12M5.25M10.38M11.9M23.25M
EBITDA Margin4.5%13.1%19.8%17.4%21.3%
Operating Income324.33K4.66M6.86M9.74M12.17M
Operating Margin1.3%11.7%13.1%14.2%11.2%
Interest Income29.55K0489.57K1.95M2.42M
Interest Expense82.43K70.35K71.98K43.01K70.35K
Other Income / Expenses(1.94M)(6.28M)(1.53M)(3.85M)(6.27M)
Income Before Tax(1.61M)1.31M5.33M5.9M5.9M
Pre-Tax Margin-6.5%3.3%10.1%8.6%5.4%
Income Tax Expense333.08K92.08K778.25K2.9M(209.56K)
Net Income(1.95M)1.21M4.55M3M6.11M
Net Margin-7.9%3.0%8.7%4.4%5.6%
EPS (Basic)(0.05)0.030.100.060.10
EPS (Diluted)(0.05)0.030.100.060.10
Weighted Avg Shares36.4M41.49M43.65M49.2M58.54M
Weighted Avg Shares (Diluted)36.4M42.56M46.6M50.93M60.29M

Vitalhub Corp.

TSX:VHI.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.